🇺🇸 FDA
Pipeline program

Sarilumab

EFC11574

Approved small_molecule terminated

Quick answer

Sarilumab for Rheumatoid Arthritis is a Approved program (small_molecule) at Regeneron UK Limited with 8 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Rheumatoid Arthritis
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials